4968
ARAKAWA CHEMICAL INDUSTRIES,LTD.
荒川化学工業
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2022
80,515
Mar 2023
79,431
Mar 2024
72,222
Mar 2025
80,236
Mar 2026
82,135
Operating profit(million JPY)
Mar 2022
3,304
Mar 2023
-2,907
Mar 2024
-2,617
Mar 2025
1,057
Mar 2026
2,500
Operating profit margin(%)
Mar 2022
4.1
Mar 2023
-3.66
Mar 2024
-3.62
Mar 2025
1.32
Mar 2026
3.04
Profit before tax(million JPY)
Mar 2022
2,941
Mar 2023
-4,652
Mar 2024
-1,418
Mar 2025
2,867
Mar 2026
2,404
Profit(million JPY)
Mar 2022
1,502
Mar 2023
-4,941
Mar 2024
-1,042
Mar 2025
2,644
Mar 2026
2,201
Total assets(million JPY)
Mar 2022
117,739
Mar 2023
119,035
Mar 2024
125,418
Mar 2025
122,297
Mar 2026
126,059
Cash and cash equivalents(million JPY)
Mar 2022
9,250
Mar 2023
9,286
Mar 2024
9,164
Mar 2025
6,434
Mar 2026
8,413
Cash flows from operating activities(million JPY)
Mar 2022
3,989
Mar 2023
-575
Mar 2024
1,157
Mar 2025
5,119
Mar 2026
4,176
Cash flows from investing activities(million JPY)
Mar 2022
-7,401
Mar 2023
-6,046
Mar 2024
-7,140
Mar 2025
-3,243
Mar 2026
-2,103
Cash flows from financing activities(million JPY)
Mar 2022
4,927
Mar 2023
6,666
Mar 2024
5,484
Mar 2025
-4,704
Mar 2026
-286
Return on equity(%)
Mar 2022
2.6
Mar 2023
-8.7
Mar 2024
-1.9
Mar 2025
4.6
Mar 2026
3.6
Equity ratio(%)
Mar 2022
50.3
Mar 2023
45.4
Mar 2024
44.8
Mar 2025
47.8
Mar 2026
49.5
Earnings per share(JPY per share)
Mar 2022
75.75
Mar 2023
-249.08
Mar 2024
-52.56
Mar 2025
133.31
Mar 2026
110.96
Net assets per share(JPY per share)
Mar 2022
2,983.23
Mar 2023
2,726.08
Mar 2024
2,829.54
Mar 2025
2,947.52
Mar 2026
3,143.24
Dividend per share(JPY per share)
Mar 2022
48
Mar 2023
48
Mar 2024
48
Mar 2025
49
Mar 2026
50
Payout ratio(%)
Mar 2022
63.37
Mar 2023
-
Mar 2024
-
Mar 2025
36.76
Mar 2026
45.06
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.